chr5-87268660-A-G
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_002890.3(RASA1):āc.209A>Gā(p.Glu70Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0018 in 1,610,944 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_002890.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RASA1 | NM_002890.3 | c.209A>G | p.Glu70Gly | missense_variant | 1/25 | ENST00000274376.11 | NP_002881.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RASA1 | ENST00000274376.11 | c.209A>G | p.Glu70Gly | missense_variant | 1/25 | 1 | NM_002890.3 | ENSP00000274376.6 | ||
RASA1 | ENST00000515800.6 | n.209A>G | non_coding_transcript_exon_variant | 1/26 | 1 | ENSP00000423395.2 |
Frequencies
GnomAD3 genomes AF: 0.00274 AC: 417AN: 152078Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00363 AC: 876AN: 241008Hom.: 6 AF XY: 0.00362 AC XY: 474AN XY: 130902
GnomAD4 exome AF: 0.00170 AC: 2478AN: 1458748Hom.: 17 Cov.: 32 AF XY: 0.00167 AC XY: 1214AN XY: 725386
GnomAD4 genome AF: 0.00274 AC: 417AN: 152196Hom.: 5 Cov.: 32 AF XY: 0.00410 AC XY: 305AN XY: 74410
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | RASA1: BS1 - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 07, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 20, 2018 | - - |
Capillary malformation-arteriovenous malformation syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Parkes Weber syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 16, 2024 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Capillary malformation-arteriovenous malformation 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at